<br>Addressing Gram-negative permeation & efflux evasion with a collaborative discovery tool</br><em> – by Wes Kim & Katie Prosen</em>
27 June 2019

Addressing Gram-negative permeation & efflux evasion with a collaborative discovery tool – by Wes Kim & Katie Prosen

more
<br>How to steward new antibiotics into low- and middle-income countries (LMICs)?</br><em> – by Marc Mendelson & Adrian Brink</em>
27 March 2019

How to steward new antibiotics into low- and middle-income countries (LMICs)? – by Marc Mendelson & Adrian Brink

more
<br>The REPAIR Impact Fund: Reflections from the first year</br><em> – by Aleks Engel</em>
28 February 2019

The REPAIR Impact Fund: Reflections from the first year – by Aleks Engel

more
<br>Turning the tide on R&D – WHO launches first data call to review pre-clinical pipeline to tackle antibiotic resistance</br><em> – by Sarah Paulin and Peter Beyer</em>
25 February 2019

Turning the tide on R&D – WHO launches first data call to review pre-clinical pipeline to tackle antibiotic resistance – by ...

more
<br>Time to pull out all the stops in the fight against superbugs</br><em> – by Kevin Outterson</em>
13 February 2019

Time to pull out all the stops in the fight against superbugs – by Kevin Outterson

more
<br>Why we need to prioritize developing antibiotics for children</br><em> – by Manica Balasegaram</em>
24 January 2019

Why we need to prioritize developing antibiotics for children – by Manica Balasegaram

more
<br>Recent approvals – do they make a difference?</br><em> – by Ursula Theuretzbacher</em>
13 December 2018

Recent approvals – do they make a difference? – by Ursula Theuretzbacher

more
<br>More than one model to stimulate antimicrobial drug development</br><em> – by Jim O’Neill</em>
14 November 2018

More than one model to stimulate antimicrobial drug development – by Jim O’Neill

more
© All Rights Reserved
✕

Newsletter

Subscribe to our newsletter to stay up-to-date about our webinars, conferences and other activities.



View previous newsletters

Go to Top